CSBR logo

Champions Oncology (CSBR) CAPEX

Annual CAPEX

$836.00 K
-$2.04 M-70.89%

April 30, 2024

Summary

Performance

1-Year Change

-70.89%

3-Year Change

-74.52%

5-Year Change

+0.24%

15-Year Change

+9.14%

CSBR CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

33.87%
CSBR annual capital expenditures is higher than 33.87% of companies in Healthcare sector

High & Low

All-time High

$3.28 M
CSBR annual capital expenditures is currently -74.52% below its historical high of $3.28 million

3-Year Low

$836.00 K
CSBR annual capital expenditures is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Apr 30, 2024
CSBR previous annual earnings announcement was published on Apr 30, 2024

Next Annual Earnings Report Date

N/A
CSBR next annual earnings announcement has not yet been scheduled

OtherCSBRcash flowmetrics:

Annual FCF

-$6.97 M
CSBR annual free cash flow is -$6.97 million

Annual CFO

-$6.14 M
CSBR annual cash flow from operations is -$6.14 million

Annual CFI

-$836.00 K
CSBR annual cash flow from investing activities is -$836.00 thousand

Annual CFF

-$527.00 K
CSBR annual cash flow from financing activities is -$527.00 thousand

Quarterly CAPEX

$94.00 K
NaN%

October 31, 2024

Summary

Performance

3-Month Change

-

1-Year Change

+18.99%

3-Year Change

+18.99%

5-Year Change

+18.99%

CSBR Quarterly CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

29.56%
CSBR quarterly capital expenditures is higher than 29.56% of companies in Healthcare sector

High & Low

All-time High

$1.53 M
CSBR quarterly capital expenditures is currently -93.84% below its historical high of $1.53 million

3-Year Low

-$111.00 K

Earnings dates

Last Quarterly Earnings Report Date

Oct 31, 2024
CSBR previous earnings announcement was published on Oct 31, 2024

Next Quarterly Earnings Report Date

Mar 12, 2025
CSBR next earnings announcement is scheduled for Mar 12, 2025

OtherCSBRcash flowmetrics:

Quarterly FCF

-$377.00 K
CSBR quarterly free cash flow is -$377.00 thousand

Quarterly CFO

-$283.00 K
CSBR quarterly cash flow from operations is -$283.00 thousand

Quarterly CFI

-$94.00 K
CSBR quarterly cash flow from investing activities is -$94.00 thousand

Quarterly CFF

$239.00 K
CSBR quarterly cash flow from financing activities is $239.00 thousand

TTM CAPEX

$183.00 K
NaN%

October 31, 2024

Summary

Performance

3-Month Change

-

1-Year Change

-91.91%

3-Year Change

-91.91%

5-Year Change

-91.91%

CSBR TTM CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

15.29%
CSBR TTM capital expenditures is higher than 15.29% of companies in Healthcare sector

High & Low

All-time High

$3.95 M
CSBR TTM capital expenditures is currently -95.37% below its historical high of $3.95 million

3-Year Low

$183.00 K
CSBR TTM capital expenditures is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Oct 31, 2024
CSBR previous earnings announcement was published on Oct 31, 2024

Next Quarterly Earnings Report Date

Mar 12, 2025
CSBR next earnings announcement is scheduled for Mar 12, 2025

OtherCSBRcash flowmetrics:

TTM FCF

-$2.89 M
CSBR TTM free cash flow is -$2.89 million

TTM CFO

-$2.71 M
CSBR TTM cash flow from operations is -$2.71 million

TTM CFI

-$183.00 K
CSBR TTM cash flow from investing activities is -$183.00 thousand

TTM CFF

$131.00 K
CSBR TTM cash flow from financing activities is $131.00 thousand

CSBR CAPEX Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-70.9%+19.0%-91.9%
3 y3 years-74.5%+19.0%-91.9%
5 y5 years+0.2%+19.0%-91.9%

CSBR CAPEX Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-74.5%at low-87.6%+184.7%-93.6%at low
5 y5-year-74.5%+0.2%-93.8%+184.7%-95.4%at low
alltimeall time-74.5%>+9999.0%-93.8%+141.4%-95.4%>+9999.0%

Champions Oncology CAPEX History

DateAnnualQuarterlyTTM
Oct 2024
-
$94.00 K(-184.7%)
$183.00 K(-78.1%)
Apr 2024
$836.00 K(-70.9%)
-$111.00 K(-155.5%)
$836.00 K(-51.0%)
Jan 2024
-
$200.00 K(+153.2%)
$1.71 M(-24.5%)
Oct 2023
-
$79.00 K(-88.2%)
$2.26 M(-18.8%)
Jul 2023
-
$668.00 K(-12.1%)
$2.79 M(-3.0%)
Apr 2023
$2.87 M(+20.5%)
$760.00 K(+0.8%)
$2.87 M(+9.7%)
Jan 2023
-
$754.00 K(+24.8%)
$2.62 M(+15.4%)
Oct 2022
-
$604.00 K(-19.9%)
$2.27 M(+1.7%)
Jul 2022
-
$754.00 K(+49.0%)
$2.23 M(-6.4%)
Apr 2022
$2.38 M(-27.3%)
$506.00 K(+24.9%)
$2.38 M(-12.7%)
Jan 2022
-
$405.00 K(-28.4%)
$2.73 M(-22.6%)
Oct 2021
-
$566.00 K(-37.6%)
$3.53 M(+1.7%)
Jul 2021
-
$907.00 K(+6.2%)
$3.47 M(+5.8%)
Apr 2021
$3.28 M(+47.8%)
$854.00 K(-29.0%)
$3.28 M(-17.0%)
Jan 2021
-
$1.20 M(+137.7%)
$3.95 M(+35.3%)
Oct 2020
-
$506.00 K(-29.5%)
$2.92 M(+33.5%)
Jul 2020
-
$718.00 K(-53.0%)
$2.19 M(-1.4%)
Apr 2020
$2.22 M(+166.2%)
$1.53 M(+793.0%)
$2.22 M(+166.2%)
Jan 2020
-
$171.00 K(-175.3%)
$834.00 K(-4.1%)
Oct 2019
-
-$227.00 K(-130.3%)
$870.00 K(-36.6%)
Jul 2019
-
$749.00 K(+431.2%)
$1.37 M(+64.5%)
Apr 2019
$834.00 K(-32.1%)
$141.00 K(-31.9%)
$834.00 K(-7.8%)
Jan 2019
-
$207.00 K(-24.7%)
$905.00 K(+17.1%)
Oct 2018
-
$275.00 K(+30.3%)
$773.00 K(+45.8%)
Jul 2018
-
$211.00 K(-0.5%)
$530.00 K(-56.9%)
Apr 2018
$1.23 M(+60.4%)
$212.00 K(+182.7%)
$1.23 M(-23.3%)
Jan 2018
-
$75.00 K(+134.4%)
$1.60 M(-4.5%)
Oct 2017
-
$32.00 K(-96.5%)
$1.68 M(+1.1%)
Jul 2017
-
$910.00 K(+55.6%)
$1.66 M(+116.6%)
Apr 2017
$766.00 K(+137.9%)
$585.00 K(+287.4%)
$766.00 K(+134.3%)
Jan 2017
-
$151.00 K(+1061.5%)
$327.00 K(+6.2%)
Oct 2016
-
$13.00 K(-23.5%)
$308.00 K(-0.6%)
Jul 2016
-
$17.00 K(-88.4%)
$310.00 K(-3.7%)
Apr 2016
$322.00 K(+170.6%)
$146.00 K(+10.6%)
$322.00 K(+52.6%)
Jan 2016
-
$132.00 K(+780.0%)
$211.00 K(+129.3%)
Oct 2015
-
$15.00 K(-48.3%)
$92.00 K(-20.0%)
Jul 2015
-
$29.00 K(-17.1%)
$115.00 K(-3.4%)
Apr 2015
$119.00 K(-49.1%)
$35.00 K(+169.2%)
$119.00 K(-22.7%)
Jan 2015
-
$13.00 K(-65.8%)
$154.00 K(-32.8%)
Oct 2014
-
$38.00 K(+15.2%)
$229.00 K(+0.9%)
Jul 2014
-
$33.00 K(-52.9%)
$227.00 K(-3.0%)
DateAnnualQuarterlyTTM
Apr 2014
$234.00 K(+310.5%)
$70.00 K(-20.5%)
$234.00 K(+25.8%)
Jan 2014
-
$88.00 K(+144.4%)
$186.00 K(+77.1%)
Oct 2013
-
$36.00 K(-10.0%)
$105.00 K(+34.6%)
Jul 2013
-
$40.00 K(+81.8%)
$78.00 K(+36.8%)
Apr 2013
$57.00 K(-89.0%)
$22.00 K(+214.3%)
$57.00 K(-68.9%)
Jan 2013
-
$7000.00(-22.2%)
$183.00 K(-52.7%)
Oct 2012
-
$9000.00(-52.6%)
$387.00 K(-12.6%)
Jul 2012
-
$19.00 K(-87.2%)
$443.00 K(-14.6%)
Apr 2012
$519.00 K(+510.6%)
$148.00 K(-29.9%)
$519.00 K(+26.9%)
Jan 2012
-
$211.00 K(+224.6%)
$409.00 K(+85.9%)
Oct 2011
-
$65.00 K(-31.6%)
$220.00 K(+37.5%)
Jul 2011
-
$95.00 K(+150.0%)
$160.00 K(+88.2%)
Apr 2011
$85.00 K(+1.2%)
$38.00 K(+72.7%)
$85.00 K(-6.6%)
Jan 2011
-
$22.00 K(+340.0%)
$91.00 K(+18.2%)
Oct 2010
-
$5000.00(-75.0%)
$77.00 K(+28.3%)
Jul 2010
-
$20.00 K(-54.5%)
$60.00 K(-28.6%)
Apr 2010
$84.00 K(-33.3%)
$44.00 K(+450.0%)
$84.00 K(-34.4%)
Jan 2010
-
$8000.00(-166.7%)
$128.00 K(-14.0%)
Oct 2009
-
-$12.00 K(-127.3%)
$148.90 K(-4.6%)
Jul 2009
-
$44.00 K(-50.0%)
$156.00 K(+23.8%)
Apr 2009
$126.00 K(+168.1%)
$88.00 K(+204.5%)
$126.00 K(+231.6%)
Jan 2009
-
$28.90 K(-689.8%)
$38.00 K(+317.6%)
Oct 2008
-
-$4900.00(-135.0%)
$9100.00(-35.0%)
Jul 2008
-
$14.00 K(>+9900.0%)
$14.00 K(+382.8%)
Apr 2008
$47.00 K(+1520.7%)
-
-
Apr 2004
$2900.00(-68.1%)
$0.00(0.0%)
$2900.00(+163.6%)
Jan 2004
-
$0.00(0.0%)
$1100.00(-57.7%)
Oct 2003
-
$0.00(-100.0%)
$2600.00(-61.2%)
Jul 2003
-
$2900.00(-261.1%)
$6700.00(-26.4%)
Apr 2003
$9100.00(-36.8%)
-$1800.00(-220.0%)
$9100.00(-49.4%)
Jan 2003
-
$1500.00(-63.4%)
$18.00 K(-22.4%)
Oct 2002
-
$4100.00(-22.6%)
$23.20 K(+17.8%)
Jul 2002
-
$5300.00(-25.4%)
$19.70 K(+36.8%)
Apr 2002
$14.40 K(-57.3%)
$7100.00(+6.0%)
$14.40 K(+97.3%)
Jan 2002
-
$6700.00(+1016.7%)
$7300.00(-2.7%)
Oct 2001
-
$600.00(>+9900.0%)
$7500.00(-77.7%)
Apr 2001
$33.70 K(+149.6%)
$0.00(-100.0%)
$33.70 K(0.0%)
Jan 2001
-
$6900.00(-40.5%)
$33.70 K(+25.7%)
Oct 2000
-
$11.60 K(-23.7%)
$26.80 K(+76.3%)
Jul 2000
-
$15.20 K
$15.20 K
Apr 2000
$13.50 K
-
-

FAQ

  • What is Champions Oncology annual capital expenditures?
  • What is the all time high annual CAPEX for Champions Oncology?
  • What is Champions Oncology annual CAPEX year-on-year change?
  • What is Champions Oncology quarterly capital expenditures?
  • What is the all time high quarterly CAPEX for Champions Oncology?
  • What is Champions Oncology quarterly CAPEX year-on-year change?
  • What is Champions Oncology TTM capital expenditures?
  • What is the all time high TTM CAPEX for Champions Oncology?
  • What is Champions Oncology TTM CAPEX year-on-year change?

What is Champions Oncology annual capital expenditures?

The current annual CAPEX of CSBR is $836.00 K

What is the all time high annual CAPEX for Champions Oncology?

Champions Oncology all-time high annual capital expenditures is $3.28 M

What is Champions Oncology annual CAPEX year-on-year change?

Over the past year, CSBR annual capital expenditures has changed by -$2.04 M (-70.89%)

What is Champions Oncology quarterly capital expenditures?

The current quarterly CAPEX of CSBR is $94.00 K

What is the all time high quarterly CAPEX for Champions Oncology?

Champions Oncology all-time high quarterly capital expenditures is $1.53 M

What is Champions Oncology quarterly CAPEX year-on-year change?

Over the past year, CSBR quarterly capital expenditures has changed by +$15.00 K (+18.99%)

What is Champions Oncology TTM capital expenditures?

The current TTM CAPEX of CSBR is $183.00 K

What is the all time high TTM CAPEX for Champions Oncology?

Champions Oncology all-time high TTM capital expenditures is $3.95 M

What is Champions Oncology TTM CAPEX year-on-year change?

Over the past year, CSBR TTM capital expenditures has changed by -$2.08 M (-91.91%)